Michael Mason, EVP, CFO & Treasurer at Karyopharm Therapeutics Inc. (KPTI), sold 652 shares at $0.99 ($645) on 2024-06-04, disclosed to the SEC on 2024-06-06.
Seasonal sale ($645) by EVP, CFO & Treasurer — this insider has traded KPTI in June in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| KPTI | SELL | 2024-02-29 | $3K | — | Filing → |
| KPTI | SELL | 2024-02-08 | $7K | — | Filing → |
| KPTI | SELL | 2023-09-05 | $9K | — | Filing → |